Focus on the workstreams: Patients as partners

21 June, 2019 | Posted in:

‘Supporting people with MS to understand and take control of their condition and how they manage it.’ are leading this workstream, with CEO George Pepper member of the ‘Raising the Bar’ steering group and Service designer Rob Sloan leading the workstream session. Objective: To develop an expert patient course designed by and for pwMS […]

Continue Reading »

MS community fight for new drug to treat primary-progressive MS

14 September, 2018 | Posted in:

New disease-modifying drug Ocrelizumab could be the treatment that many people with primary-progressive MS have been waiting for, but despite positive clinical outcomes, it has yet to be licensed here in the UK. Multiple sclerosis (MS) causes inflammation of the nerve cells in the brain and spine, and disease-modifying therapies (DMTs) are a form of […]

Continue Reading »

Technology advances in neurology healthcare

31 August, 2018 | Posted in:

We live in a technological era and seldom a moment goes by when we are not using some sort of device or app, browsing the internet or relating across social media. Healthcare has long seemed behind in using these advances in technology to improve their services, but this is beginning to change. Exciting headway From […]

Continue Reading »

Changes to diagnostic criteria in MS to improve speed and accuracy of diagnosis

20 July, 2018 | Posted in:

Experts in multiple sclerosis (MS) have recently recommended changes to the widely used diagnostic criteria for the condition. The McDonald criteria, first published in 2010, allows diagnosis of MS after one relapse, if an MRI imaging scan shows evidence of damage to the brain through lesions developing. Lately experts have gathered to review the criteria, […]

Continue Reading »

GIRFT (Get it Right First Time) – Parkinson’s and MS services to be reviewed in National Census

31 May, 2018 | Posted in:

Following the successful completion of a quality improvement pilot in orthopaedic surgery entitled Getting It Right First Time (GIRFT), the Department of Health and NHS Improvement (NHSI) have commissioned an expansion of the GIRFT programme that will cover an additional 35 clinical areas over four years from April 2017 to support providers in delivering clinical […]

Continue Reading »

MS MasterClass graduate has course-based research published by ABN

16 May, 2018 | Posted in:

We are delighted to announce that Dr Bindu Yoga, an MS MasterClass graduate, has recently had a poster selected by the Association of British Neurologists (ABN) for her work on timely access to disease-modifying treatments (DMTs) in multiple sclerosis (MS). Current guidelines say treatment should start ‘as soon as possible’ after a decision is made, […]

Continue Reading »

Invitation to an evening debate on 9 May

25 April, 2018 | Posted in:

You may be aware of the new ‘Recommendations for an NHS England algorithm to use disease-modifying drugs to treat Multiple Sclerosis’ is currently out for public consultation. The algorithm raises several issues for clinical practice. We are hosting an evening dinner in the ICC where the Association of British Neurologists (ABN) is being held, on […]

Continue Reading »